MRNA ▲ +1.1% - Moderna, Inc. $MRNA - Moderna Announces Pricing of Upsized $2.6 Billion Offering of Convertible Senior Notes Moderna's stock rose 1.1% following the company's announcement of a $2.6 billion convertible senior notes offering. The upsized offering—larger than originally planned—suggests strong investor demand for the debt instrument, which typically indicates confidence in the company's financial position and future prospects. 28-AUG-2026 07:00 AM ET